What drove Zenotech's net loss in Q1 FY27?

Total expenses rose to ₹1,164.86 lakh from ₹895.48 lakh, driven by higher employee and other costs, outpacing an 11% revenue increase.

How much did Zenotech's revenue grow?

Revenue from operations grew 11% to ₹959.64 lakh.

When is Zenotech's 37th AGM?

The AGM is scheduled for 25 September 2026 via videoconference.

What was Zenotech's profit in the same quarter last year?

It recorded a profit of ₹98.96 lakh in Q1 FY26.

Is Zenotech debt-free?

Yes, the company has zero debt according to trailing data.

How does this result fit with Zenotech's trailing performance?

Trailing PAT had already declined 356%, so this loss extends a deteriorating trend.

Earnings · Pharmaceuticals · Micro cap

Zenotech posts ₹45.55 lakh net loss in Q1 as costs surge

Zenotech Laboratories swung to a net loss of ₹45.55 lakh in Q1 FY27 from a profit of ₹98.96 lakh a year earlier, as expenses outpaced revenue growth of 11%.

— 1 earlier story on Zenotech Laboratories Ltd. →

ZENOTECH By Tipsheet Editorial 28 Jul 2026 · 2:44 PM IST Verify on BSE · NSE

Mkt cap₹279 cr

ROE5.84%

Debt / eq.0.00

₹45.55 lakh Net loss in Q1 FY27 vs profit a year earlier

What's new

Zenotech reported a net loss of ₹45.55 lakh in Q1 FY27, reversing a profit of ₹98.96 lakh.
Revenue rose 11% to ₹959.64 lakh but total expenses rose to ₹1,164.86 lakh from ₹895.48 lakh.
Board scheduled 37th AGM for 25 September 2026 via videoconference.

Why this matters

For a company with a market cap of just ₹279 cr, a swing from profit to loss in a single quarter is significant. Employee and other costs are squeezing margins. The question is whether management can contain the cost surge without sacrificing growth.

What we're watching

Whether the company can rein in expenses in coming quarters.
Any explanation from management on the cost increase.
Impact on the full-year outlook for a nano-cap pharma.

The full read

Zenotech Laboratories reported a net loss of ₹45.55 lakh in Q1 FY27, swinging from a ₹98.96 lakh profit a year earlier. Revenue crept up 11% to ₹959.64 lakh, but costs surged to ₹1,164.86 lakh — a 30% jump. The culprit: higher employee and other expenses. For a ₹279 cr market-cap pharma with zero debt, the loss isn't terminal, but it's a sharp reversal. Trailing PAT was already down 356%; this quarter accelerates the slide. The AGM notice is routine. The real question is whether management can contain costs without sacrificing the revenue growth that is still there.

Questions answered

What drove Zenotech's net loss in Q1 FY27?: Total expenses rose to ₹1,164.86 lakh from ₹895.48 lakh, driven by higher employee and other costs, outpacing an 11% revenue increase.
How much did Zenotech's revenue grow?: Revenue from operations grew 11% to ₹959.64 lakh.
When is Zenotech's 37th AGM?: The AGM is scheduled for 25 September 2026 via videoconference.
What was Zenotech's profit in the same quarter last year?: It recorded a profit of ₹98.96 lakh in Q1 FY26.
Is Zenotech debt-free?: Yes, the company has zero debt according to trailing data.
How does this result fit with Zenotech's trailing performance?: Trailing PAT had already declined 356%, so this loss extends a deteriorating trend.

Mentioned: Zenotech Laboratories · Q1 FY27 · ₹45.55 lakh loss

Primary source BSE · NSE

An independent reading of the company's own disclosure — the primary filing above is the final word.

Story so far

All notes on ZENOTECH →

28 Jul 2026 · 2:44 PM IST Zenotech posts ₹45.55 lakh net loss in Q1 as costs surge
today Zenotech swings to ₹45.55 lakh net loss in Q1 on higher costs